GBA1 and Parkinson disease: On the basis of these data, we hypothesized that the reduced microglial neuroprotective functions might contribute to the observed increased risk of PD in carriers of GBA1 mutations and prompted us to analyze the microglial morpho-functionality after GCase inhibition.